Cargando…

Surgical Treatment of Distal Cholangiocarcinoma

Distal cholangiocarcinoma (dCCA) is a rare malignancy arising from the epithelial cells of the distal biliary tract and has a poor prognosis. dCCA is often clinically silent and patients commonly present with locally advanced and/or distant disease. For patients identified with early stage, resectab...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorji, Leva, Beal, Eliza W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498206/
https://www.ncbi.nlm.nih.gov/pubmed/36135093
http://dx.doi.org/10.3390/curroncol29090524
_version_ 1784794699824889856
author Gorji, Leva
Beal, Eliza W.
author_facet Gorji, Leva
Beal, Eliza W.
author_sort Gorji, Leva
collection PubMed
description Distal cholangiocarcinoma (dCCA) is a rare malignancy arising from the epithelial cells of the distal biliary tract and has a poor prognosis. dCCA is often clinically silent and patients commonly present with locally advanced and/or distant disease. For patients identified with early stage, resectable disease, surgical resection with negative margins remains the only curative treatment strategy available. However, despite appropriate treatment and diligent surveillance, risk of recurrence remains high with nearly 50% of patients experiencing recurrence at 5 years subsequent to surgical resection; therefore, it is prudent to continue to optimize neoadjuvant and adjuvant therapies in order to reduce the risk of recurrence and improve overall survival. In this review, we discuss the clinical presentation, workup and surgical treatment of dCCA.
format Online
Article
Text
id pubmed-9498206
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94982062022-09-23 Surgical Treatment of Distal Cholangiocarcinoma Gorji, Leva Beal, Eliza W. Curr Oncol Review Distal cholangiocarcinoma (dCCA) is a rare malignancy arising from the epithelial cells of the distal biliary tract and has a poor prognosis. dCCA is often clinically silent and patients commonly present with locally advanced and/or distant disease. For patients identified with early stage, resectable disease, surgical resection with negative margins remains the only curative treatment strategy available. However, despite appropriate treatment and diligent surveillance, risk of recurrence remains high with nearly 50% of patients experiencing recurrence at 5 years subsequent to surgical resection; therefore, it is prudent to continue to optimize neoadjuvant and adjuvant therapies in order to reduce the risk of recurrence and improve overall survival. In this review, we discuss the clinical presentation, workup and surgical treatment of dCCA. MDPI 2022-09-17 /pmc/articles/PMC9498206/ /pubmed/36135093 http://dx.doi.org/10.3390/curroncol29090524 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Gorji, Leva
Beal, Eliza W.
Surgical Treatment of Distal Cholangiocarcinoma
title Surgical Treatment of Distal Cholangiocarcinoma
title_full Surgical Treatment of Distal Cholangiocarcinoma
title_fullStr Surgical Treatment of Distal Cholangiocarcinoma
title_full_unstemmed Surgical Treatment of Distal Cholangiocarcinoma
title_short Surgical Treatment of Distal Cholangiocarcinoma
title_sort surgical treatment of distal cholangiocarcinoma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498206/
https://www.ncbi.nlm.nih.gov/pubmed/36135093
http://dx.doi.org/10.3390/curroncol29090524
work_keys_str_mv AT gorjileva surgicaltreatmentofdistalcholangiocarcinoma
AT bealelizaw surgicaltreatmentofdistalcholangiocarcinoma